A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.
Charlotte AndriessenMarieke T BlomBeryl A C E van HoekAnna W de BoerPetra DenigG Ardine de WitKarin SwartAngela de Rooij-PeekRob J van MarumJacqueline G HugtenburgPauline SlottjeDaniël van RaalteLiselotte van BloemendaalRon HeringsGiel NijpelsRimke C VosPetra J M EldersPublished in: Trials (2024)
ISRCTN Registry, ISRCTN50008265 , registered 09 March, 2023.